Neptune-Calculus Income &Growth VCT Directorate Change (3229D)
April 25 2017 - 11:39AM
UK Regulatory
TIDMNEP TIDMTTM
RNS Number : 3229D
Neptune-Calculus Income &Growth VCT
25 April 2017
Neptune-Calculus Income & Growth VCT (the Company)
Appointment of non-executive Chairman and investment update.
New Chairman
It was announced on 21 March 2017 that Philip Stephens, who has
served as Chairman of the Company since its launch in 2004, had
decided to retire from the Board at the Annual General Meeting to
be held on 22 June 2017 and that a number of candidates were being
considered to replace him. The Board of Neptune-Calculus Income and
Growth VCT is pleased to announce that Diane Seymour-Williams will
be appointed as Non-Executive Chairman of the Company immediately
following the AGM.
Diane's executive career includes 23 years at Morgan
Grenfell/Deutsche Asset Management where she became Head of Global
Equity Products and 9 years at LGM Investments where she was Global
Head of Relationship Management.
Her previous fund directorships include The China Fund
(1993-2005), Pakistan Fund (1993-1996), Batavia Fund (1993-1996),
and Chairman Greater Korea Trust (1993-1997). She has also served
as a director on the Boards of BMO Investments (Ireland) plc (2013
to 2016), BMO Investments II (Ireland) plc (2008 to 2016), Irish
domiciled UCITS companies and LG China Fund plc (2009 to 2017) also
domiciled in Ireland. For 5 years from 2007, Diane was a
non-executive director of Calculus Capital Limited.
Diane is currently a non-executive director of Witan Pacific
Investment Trust plc and Brooks Macdonald Group plc, where, in
addition, she chairs the Remuneration Committee. She also serves on
the Newnham College Cambridge Investment Committee.
Diane holds 54,504 Ordinary shares in Neptune-Calculus Income
and Growth VCT plc. In accordance with paragraph 9.6.13 (2) - (6)
of the Listing Rules, Diane Seymour-Williams has advised that she
has no details to disclose.
Investment update
The net asset value per share at 31 March 2017 was 32.60p, a
modest increase since 31 December 2016, the Company's year end.
Since 21 March 2017, the date of the Company's 2016 results
announcement, the Company's holding of shares in RMS Europe Limited
has been sold at carrying value which was over 5 times the original
cost of the shares and the Company has invested GBP100,000 in
Synpromics, an Edinburgh-based synthetic biology company alongside
other funds managed by Calculus Capital Limited, Scottish
Enterprise and a group of private investors. Synpromics is
developing a portfolio of synthetic promoters for application
across target markets which include Cell and Gene Therapy,
Bioprocessing and Agriculture.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAPGUMWCUPMGQA
(END) Dow Jones Newswires
April 25, 2017 12:39 ET (16:39 GMT)
Neptune-calculus Inc&growth Vct (LSE:NEP)
Historical Stock Chart
From Apr 2024 to May 2024
Neptune-calculus Inc&growth Vct (LSE:NEP)
Historical Stock Chart
From May 2023 to May 2024